Shomron Ben-Horin (S Ben-Horin, Shomron Ben Horin)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Ulcerative Colitis

Top Venues

Alimentary pharmacology & therapeutics

Clinical drug investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Maya Granot, Uri Kopylov, Nurit Loberman-Nachum, Alexander Krauthammer, Chaya Mushka Abitbol, Shomron Ben-Horin, Batia Weiss, Yael Haberman
Differences in disease characteristics and treatment exposures between paediatric and adult-onset inflammatory bowel disease using a registry-based cohort. Alimentary pharmacology & therapeutics (2024)
David K Choi, Shomron Ben-Horin
Editorial: Finger in the dam-A clinical trial of long-acting somatostatin for high-output ostomies and fistulas. Alimentary pharmacology & therapeutics (2024)
Offir Ukashi, Shelly Soffer, Eyal Klang, Rami Eliakim, Shomron Ben-Horin, Uri Kopylov
Capsule Endoscopy in Inflammatory Bowel Disease: Panenteric Capsule Endoscopy and Application of Artificial Intelligence. Gut and liver (2023)
Geert R A M D'Haens, Walter Reinisch, Stefan Schreiber, Fraser Cummings, Peter M Irving, Byong Duk Ye, Dong-Hyeon Kim, Sangwook Yoon, Shomron Ben-Horin
Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial. Clinical drug investigation (2023)
Ido Veisman, Shomron Ben-Horin
Editorial: tofacitinib post-marketing safety reports among ulcerative colitis patients. Alimentary pharmacology & therapeutics 55 (1) (2022)
Bella Ungar, Miri Yavzori, Ella Fudim, Orit Picard, Uri Kopylov, Rami Eliakim, Dror Shouval, Yishai Levin, Alon Savidor, Shani Ben-Moshe, Rita Manco, Stav Dan, Adi Egozi, Keren Bahar Halpern, Chen Mayer, Iris Barshack, Shomron Ben-Horin, Shalev Itzkovitz
Host transcriptome signatures in human faecal-washes predict histological remission in patients with IBD. Gut (2022)
Shomron Ben-Horin, Bella Ungar
Letter: loss of response to anti-TNFα agents in patients with inflammatory bowel disease depends on treatment duration. Alimentary pharmacology & therapeutics 55 (4) (2022)
Min Zhao, Rui Feng, Shomron Ben-Horin, Xiaojun Zhuang, Zhenyi Tian, Xiaozhi Li, Ruiqi Ma, Ren Mao, Yun Qiu, Minhu Chen
Systematic review with meta-analysis: environmental and dietary differences of inflammatory bowel disease in Eastern and Western populations. Alimentary pharmacology & therapeutics (2021)
Dror S Shouval, Shomron Ben-Horin
Editorial: biomarker predictors of non-response to TNFα antagonists-the quest continues. Alimentary pharmacology & therapeutics 49 (8) (2020)
Ahmad Albshesh, Shomron Ben-Horin
Editorial: which biologic is next for ulcerative colitis patients who fail a subcutaneous anti-TNF? Alimentary pharmacology & therapeutics 51 (11) (2020)
Shomron Ben-Horin
Editorial: restoring therapeutic infliximab drug levels in patients with loss of response-pharmacokinetics and anti-drug antibodies as useful guidance tools. Alimentary pharmacology & therapeutics 47 (6) (2019)
Joao Goncalves, Fernando Magro, Silvio Danese, Peter Laszlo Lakatos, Shomron Ben-Horin
Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors' reply. Alimentary pharmacology & therapeutics 48 (5) (2019)
Bella Ungar, Shomron Ben-Horin, Xavier Roblin
Letter: double-dose intensification-a quick way to reverse antibody formation and loss of response in patients treated with adalimumab. Authors reply. Alimentary pharmacology & therapeutics 49 (6) (2019)
Shaji Sebastian, Christopher Black, Daniela Pugliese, Alessandro Armuzzi, Kapil Sahnan, Soad M Elkady, Kostas H Katsanos, Demitrios K Christodoulou, Christian Selinger, Giovanni Maconi, Nicola S Fearnhead, Uri Kopylov, Yana Davidov, Marta Maia Bosca-Watts, Pierre Ellul, Martina Muscat, Konstantinos Karmiris, Ailsa L Hart, Silvio Danese, Shomron Ben-Horin, Gionata Fiorino
The role of multimodal treatment in Crohn's disease patients with perianal fistula: a multicentre retrospective cohort study. Alimentary pharmacology & therapeutics 48 (9) (2018)
Shomron Ben-Horin, Bella Ungar, Uri Kopylov, Adi Lahat, M Yavzori, E Fudim, O Picard, Y Peled, R Eliakim, E Del Tedesco, Stephane Paul, Xavier Roblin
Safety, efficacy and pharmacokinetics of vedolizumab in patients with simultaneous exposure to an anti-tumour necrosis factor. Alimentary pharmacology & therapeutics 47 (8) (2018)